Connect
Stomach cancer, often detected in advanced stages, can be challenging to cure. Mayo Clinic experts are pioneering a new treatment called hyperthermic intraperitoneal chemotherapy (HIPEC) to improve outcomes for patients with late-stage stomach cancers.
HIPEC involves bathing the abdominal cavity with heated chemotherapy, targeting cancer cells directly at the source. This localized approach allows for higher concentrations of chemotherapy to remain in the abdomen, working to kill microscopic cancer cells even after the procedure, explains, Dr. Travis Grotz, a Mayo Clinic surgical oncologist at Mayo Clinic.
Though HIPEC has been used for other cancers for decades, its adaptation for stomach cancer is recent. Mayo Clinic’s customized combination of chemotherapy drugs has shown promising results, yielding better outcomes than traditional systemic chemotherapy.
Dr. Grotz emphasizes that ongoing research aims to further enhance survival rates and improve the quality of life for patients, ensuring safer treatments with fewer complications. This innovative approach brings hope to those battling advanced stomach cancer.
Like
Helpful
Hug
Connect